128 related articles for article (PubMed ID: 36252203)
21. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
22. A functional screen identifies miRs that induce radioresistance in glioblastomas.
Moskwa P; Zinn PO; Choi YE; Shukla SA; Fendler W; Chen CC; Lu J; Golub TR; Hjelmeland A; Chowdhury D
Mol Cancer Res; 2014 Dec; 12(12):1767-78. PubMed ID: 25256711
[TBL] [Abstract][Full Text] [Related]
23. Nucleus pulposus cells upregulate PI3K/Akt and MEK/ERK signaling pathways under hypoxic conditions and resist apoptosis induced by serum withdrawal.
Risbud MV; Fertala J; Vresilovic EJ; Albert TJ; Shapiro IM
Spine (Phila Pa 1976); 2005 Apr; 30(8):882-9. PubMed ID: 15834331
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.
Steelman LS; Navolanic P; Chappell WH; Abrams SL; Wong EW; Martelli AM; Cocco L; Stivala F; Libra M; Nicoletti F; Drobot LB; Franklin RA; McCubrey JA
Cell Cycle; 2011 Sep; 10(17):3003-15. PubMed ID: 21869603
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms regulating radiosensitivity of glioma stem cells.
Liu Y; Shen Y; Sun T; Yang W
Neoplasma; 2017; 64(5):655-665. PubMed ID: 28592117
[TBL] [Abstract][Full Text] [Related]
26. Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development.
El-Habr EA; Levidou G; Trigka EA; Sakalidou J; Piperi C; Chatziandreou I; Spyropoulou A; Soldatos R; Tomara G; Petraki K; Samaras V; Zisakis A; Varsos V; Vrettakos G; Boviatsis E; Patsouris E; Saetta AA; Korkolopoulou P
Virchows Arch; 2014 Oct; 465(4):473-85. PubMed ID: 25146167
[TBL] [Abstract][Full Text] [Related]
27. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
[TBL] [Abstract][Full Text] [Related]
28. Combining radiation with PI3K isoform-selective inhibitor administration increases radiosensitivity and suppresses tumor growth in non-small cell lung cancer.
Seol MY; Choi SH; Yoon HI
J Radiat Res; 2022 Jul; 63(4):591-601. PubMed ID: 35536306
[TBL] [Abstract][Full Text] [Related]
29. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.
He Y; Mingyan E; Wang C; Liu G; Shi M; Liu S
Int J Biol Macromol; 2019 Mar; 125():116-123. PubMed ID: 30508543
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.
Djuzenova CS; Fiedler V; Memmel S; Katzer A; Sisario D; Brosch PK; Göhrung A; Frister S; Zimmermann H; Flentje M; Sukhorukov VL
BMC Cancer; 2019 Apr; 19(1):299. PubMed ID: 30943918
[TBL] [Abstract][Full Text] [Related]
31. Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy.
Hu T; Zhou R; Zhao Y; Wu G
Sci Rep; 2016 Sep; 6():33376. PubMed ID: 27624978
[TBL] [Abstract][Full Text] [Related]
32. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
33. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
34. Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.
Zhang H; Luo H; Hu Z; Peng J; Jiang Z; Song T; Wu B; Yue J; Zhou R; Xie R; Chen T; Wu S
Oncotarget; 2015 Mar; 6(8):6218-34. PubMed ID: 25749038
[TBL] [Abstract][Full Text] [Related]
35. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
Yacoub A; Mitchell C; Hong Y; Gopalkrishnan RV; Su ZZ; Gupta P; Sauane M; Lebedeva IV; Curiel DT; Mahasreshti PJ; Rosenfeld MR; Broaddus WC; James CD; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2004 Aug; 3(8):739-51. PubMed ID: 15197348
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor ATF3 mediates the radioresistance of breast cancer.
Zhao W; Sun M; Li S; Chen Z; Geng D
J Cell Mol Med; 2018 Oct; 22(10):4664-4675. PubMed ID: 30117642
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
38. A novel role for NFIA in restoring radiosensitivity in radioresistant NSCLC cells by downregulating the AKT and ERK pathways.
Sun C; Li Y; Tan Y; Zhang H; Liang Y; Zeng J; Yu J; Zou H
Biochem Biophys Res Commun; 2019 Aug; 515(4):558-564. PubMed ID: 31178144
[TBL] [Abstract][Full Text] [Related]
39. Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells.
Shelton JG; Blalock WL; White ER; Steelman LS; McCubrey JA
Cell Cycle; 2004 Apr; 3(4):503-12. PubMed ID: 15004527
[TBL] [Abstract][Full Text] [Related]
40. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
